OPKO Health, Inc. (OPK)

Last Price:  

Company Description

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $1.44B
Net Income (Most Recent Fiscal Year) $30.59M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) 32.73
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 1.28
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.41
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 20.65
Pre-Tax Margin (Trailing 12 Months) 4.55%
Net Margin (Trailing 12 Months) 3.71%
Return on Equity (Trailing 12 Months) 4.21%
Return on Assets (Trailing 12 Months) 2.90%
Current Ratio (Most Recent Fiscal Quarter) 1.80
Quick Ratio (Most Recent Fiscal Quarter) 1.36
Debt to Common Equity (Most Recent Fiscal Quarter) 0.11
Inventory Turnover (Trailing 12 Months) 9.28
Book Value per Share (Most Recent Fiscal Quarter) $2.49
Earnings per Share (Most Recent Fiscal Quarter) $-0.03
Earnings per Share (Most Recent Fiscal Year) $0.05
Diluted Earnings per Share (Trailing 12 Months) $0.11
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Common Shares Outstanding 681.16M
Free Float 398.69M
Market Capitalization $2.45B
Average Volume (Last 20 Days) 2.04M
Beta (Past 60 Months) 1.75
Percentage Held By Insiders (Latest Annual Proxy Report) 41.47%
Percentage Held By Institutions (Latest 13F Reports) 27.56%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%